Roche, the Swiss drugmaker, said it has deployed Nvidia Blackwell GPUs across sites in the US and Europe to expand its AI computing capacity for drug and diagnostics development.
The hardware will help accelerate modelling, data analysis, and clinical trial work, adding that the rollout gives Roche what it describes as the largest GPU footprint in the pharmaceutical industry.
Roche said the build-out began in 2023 and is part of a broader collaboration with Nvidia as the company steps up investment in AI tools.
Wafaa Mamilli, chief digital and technology officer, said time is the most critical variable in healthcare.
Consultancy McKinsey also estimated that agentic AI, which requires little human intervention, could lift clinical development productivity by about 35 to 45 percent over the next five years.
🔗 Source: Reuters
Originally written by: Grace Priscilla Teo
Source: Tech in Asia
Published on: 17 March 2026
Link to original article: Roche scales AI infrastructure with Nvidia GPUs
